Summarized by Masters of Longevity from Singularity Hub.
Reports a clinical trial using an optogenetic gene therapy plus light-delivery goggles to restore limited vision in people with advanced retinal degeneration.
Key Takeaways
- Seven of ten treated patients showed improved light sensitivity after receiving the optogenetic gene therapy.
- With augmentation goggles, six of ten participants achieved clinically meaningful vision gains, including object reaching and orientation tasks.
- Responders retained visual improvements for roughly five years and most adverse events were transient ocular inflammation.
